Tag: astragalusHuangQi

Articles

• Supplements with warnings for breast cancer

News

09/11/11

Calycosin in astragalus root (huang qi) promotes ER+ proliferation

Studies

• Fabrication and Characterization of a Three-Dimensional Fibrin Gel Model to Evaluate Anti-Proliferative Effects of Astragalus hamosus Plant Extract on Breast Cancer Cells Cite
  Mahmoodi M, Ebrahimi -Barough S, Kamian S, Azami M, Mehri M, Abdi M, et al. Fabrication and Characterization of a Three-Dimensional Fibrin Gel Model to Evaluate Anti-Proliferative Effects of Astragalus hamosus Plant Extract on Breast Cancer Cells. Asian Pacific Journal of Cancer Prevention. EpiSmart Science Vector Ltd; 2022; 23:731-741 10.31557/apjcp.2022.23.2.731
• Efficacy of Rubus coreanus Miq. and Astragalus membranaceus Bunge Extract for Postmenopausal Syndrome: A Randomised, Double-Blind, Placebo Comparative Clinical Trial Cite
  Park J, Sung HK, Kim S, Lee HS, Shin SM. Efficacy of Rubus coreanus Miq. and Astragalus membranaceus Bunge Extract for Postmenopausal Syndrome: A Randomised, Double-Blind, Placebo Comparative Clinical Trial. Evidence-Based Complementary and Alternative Medicine. Hindawi Limited; 2022; 2022:1-8 10.1155/2022/4066054
• Two Worlds Colliding: The Interplay Between Natural Compounds and Non-Coding Transcripts in Cancer Therapy Cite
  Sabo AA, Dudau M, Constantin GL, Pop TC, Geilfus C, Naccarati A, et al. Two Worlds Colliding: The Interplay Between Natural Compounds and Non-Coding Transcripts in Cancer Therapy. Frontiers in Pharmacology. Frontiers Media SA; 2021; 12 10.3389/fphar.2021.652074
• Astragalus IV Undermines Multi-Drug Resistance and Glycolysis of MDA-MB-231/ADR Cell Line by Depressing hsa_circ_0001982-miR-206/miR-613 Axis Cite
  Li H, Xia Z, Liu L, Pan G, Ding J, Liu J, et al. Astragalus IV Undermines Multi-Drug Resistance and Glycolysis of MDA-MB-231/ADR Cell Line by Depressing hsa_circ_0001982-miR-206/miR-613 Axis. Cancer Management and Research. Informa UK Limited; 2021; Volume 13:5821-5833 10.2147/cmar.s297008
• Cytotoxicity and growth-inhibiting activity of Astragalus polysaccharides against breast cancer via the regulation of EGFR and ANXA1 Cite
  Li W, Hu X, Li Y, Song K. Cytotoxicity and growth-inhibiting activity of Astragalus polysaccharides against breast cancer via the regulation of EGFR and ANXA1. Journal of Natural Medicines. Springer Science and Business Media LLC; 2021; 10.1007/s11418-021-01525-x
• Pharmaceutical Values of Calycosin: One Type of Flavonoid Isolated from Astragalus Cite
  Gong G, Zheng Y, Yang Y, Sui Y, Wen Z. Pharmaceutical Values of Calycosin: One Type of Flavonoid Isolated from Astragalus. Evidence-Based Complementary and Alternative Medicine. Hindawi Limited; 2021; 2021:1-9 10.1155/2021/9952578
• Calycosin stimulates the proliferation of endothelial cells, but not breast cancer cells, via a feedback loop involving RP11-65M17.3, BRIP1 and ERα Cite
  Wang Y, Xie W, Hou M, Tian J, Zhang X, Ren Q, et al. Calycosin stimulates the proliferation of endothelial cells, but not breast cancer cells, via a feedback loop involving RP11-65M17.3, BRIP1 and ERα. Aging. Impact Journals, LLC; 2021; 10.18632/aging.202641
• Effects of dietary patterns combined with dietary phytochemicals on breast cancer metastasis Cite
  Pang S, Jia M, Gao J, Liu X, Guo W, Zhang H. Effects of dietary patterns combined with dietary phytochemicals on breast cancer metastasis. Life Sciences. Elsevier BV; 2020; 264:118720 10.1016/j.lfs.2020.118720
• Effect of dietary phytochemicals on the progression of breast cancer metastasis based on the in vivo detection of circulating tumor cells Cite
  Jia M, Pang S, Liu X, Mao Y, Wu C, Zhang H. Effect of dietary phytochemicals on the progression of breast cancer metastasis based on the in vivo detection of circulating tumor cells. Journal of Functional Foods. Elsevier BV; 2020; 65:103752 10.1016/j.jff.2019.103752
• Herbal Medications in Cardiovascular Medicine Cite
  Liperoti R, Vetrano DL, Bernabei R, Onder G. Herbal Medications in Cardiovascular Medicine. Journal of the American College of Cardiology. Elsevier BV; 2017; 69:1188-1199 10.1016/j.jacc.2016.11.078
• BreastDefend™ prevents breast-to-lung cancer metastases in an orthotopic animal model of triple-negative human breast cancer Cite
  JIANG J, THYAGARAJAN-SAHU A, LOGANATHAN J, ELIAZ I, TERRY C, SANDUSKY GE, et al. BreastDefend™ prevents breast-to-lung cancer metastases in an orthotopic animal model of triple-negative human breast cancer. Oncology Reports. Spandidos Publications; 2012; 28:1139-1145 10.3892/or.2012.1936
• Calycosin promotes proliferation of estrogen receptor-positive cells via estrogen receptors and ERK1/2 activation in vitro and in vivo Cite
  Chen J, Liu L, Hou R, Shao Z, Wu Y, Chen X, et al. Calycosin promotes proliferation of estrogen receptor-positive cells via estrogen receptors and ERK1/2 activation in vitro and in vivo. Cancer Letters. Elsevier BV; 2011; 308:144-151 10.1016/j.canlet.2011.04.022
• Estrogenicity of medicinal botanicals used as immune modulators Cite
  Elm MS, Houghton FD, Eagon PK. Estrogenicity of medicinal botanicals used as immune modulators. Cancer Research. American Association for Cancer Research; 2005; 65:1360-1360. https://cancerres.aacrjournals.org/content/65/9_Supplement/1360.2.abstract
• Effect of medicinal botanicals in breast cancer cell lines with different estrogen receptor expression Cite
  Houghton FD, Elm MS, Eagon PK. Effect of medicinal botanicals in breast cancer cell lines with different estrogen receptor expression. Cancer Res. American Association for Cancer Research; 2005; 65:1360-1360. https://cancerres.aacrjournals.org/content/65/9_Supplement/1360.3.abstract